Roche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simps...

Roche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The...

In 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...

Zydus Cadila has introduced a breast cancer drug in India that is a copy of Swiss giant Roche’s product Herceptin, which had global sales o...

In a statement to ET, Roche said it welcomed the decision of the court, which has upheld the patent covering erlotinib hydrochloride.

Roche Products (India) Private Ltd is a wholly owned subsidiary of the Switzerland based Roche Group and has products in therapeutic areas .

India is a fragmented market and has its own challenges; there is a private sector and public sector. About 80% of the healthcare expenses ...

Roche said patients will be offered equated monthly instalment schemes for Perjeta and Kadcyla through financial institutions in the coming...

Schwan says India’s healthcare spend relative to GDP is very low, compared to economies such as China which spends about 5% to 6% of its GD...

Indian authorities have for the second time rejected Swiss drug maker Roche’s patent claims on valganciclovir, or Valcyte, used to treat an...

The development comes after a division bench of the Delhi HC referred the companies to a mediation that both firms chose to accept.

Bangalore-based Biocon and US generic drugmaker Mylan have challenged Delhi High Court’s interim order which barred them from using Roche’s...

Priced at Rs 19,500 per vial, Biocon is expecting to target close to 35,000 patients with this drug.

Biocon officials confirmed the development to ET but didn't shed light on how soon the company would be ready to bring the biosimilar to th...

Roche, a Swiss drugmaker, lost the patent in India on its anti-viral drug Valcyte, widely used by AIDS patients, after the patent office co...

The SC asked the Chennai patent office to hear and take a final view for all post-grant oppositions for a patent it had granted to Swiss co...

The Supreme Court (SC) has asked Swiss company Roche not to pursue the patent violation case against the generic version of Cipla’s anti-in...